Congenital Adrenal Hyperplasia

New England Journal of Medicine

Volumn 316, Issue 24, 1987, Pages 1519-1524

  White, Perrin C ^a   New, Maria I ^a   Dupont, bo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROGESTERONE;

CONGENITAL ADRENAL HYPERPLASIA; CONGENITAL DISORDER; DIAGNOSIS; ENDOCRINE SYSTEM; ETIOLOGY; HUMAN; PRIORITY JOURNAL; REVIEW;

ADRENAL HYPERPLASIA, CONGENITAL; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023227541     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198706113162406     Document Type: Review

References (51)

1. New MI, Dupont B, Grumbach K, Levine LS. Congenital adrenal hyperplasia and related conditions. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. 5th ed. New York: McGraw-Hill, 1983:973–1000.
2. Bongiovanni AM, Root AW. The adrenogenital syndrome. N Engl J Med 1963; 268: 1283–9, 1342–51, 1391–9.
3. Watson JD, Tooze J, Kurtz DT. Recombinant DNA: a short course. New York: Scientific American Books, 1983.
4. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1982.
5. Finkelstein M, Schaefer JM. Inborn errors of steroid biosynthesis. Physiol Rev 1979; 59: 353–406.
6. Boggaram V, Funkenstein B, Waterman MR, Simpson ER. Lipoproteins and the regulation of adrenal steroidogenesis. Endocr Res 1985; 10: 387–409.
7. Pedersen RC, Brownie achéal. Steroidogenesis-activator polypeptide isolated from a rat Leydig cell tumor. Science 1987; 236: 188–90.
8. Takikawa O, Gomi T, Suhara K, Itagaki E, Takemori S, Katagiri M. Properties of an adrenal cytochrome P-450 (P-450scc) for the side chain cleavage of cholesterol. Arch Biochem Biophys 1978; 190: 300–6.
9. Ishii-Ohba H, Saiki N, Inano H, Tamaoki B-I. Purification and characterization of rat adrenal 3β-hydroxysteroid dehydrogenase with steroid 5-ene-4-ene-isomerase. J Steroid Biochem 1986; 24: 753–60.
10. Kominami S, Shinzawa K, Takemori S. Purification and some properties of cytochrome P-450 specific for steroid 17α-hydroxylation and C17–C20 bond cleavage from guinea pig adrenal microsomes. Biochem Biophys Res Commun 1982; 109: 916–21.
11. Nakajin S, Shinoda M, Haniu M, Shively JE, Hall PF. C21 steroid side chain cleavage enzyme from porcine adrenal microsomes: purification and characterization of the 17α-hydroxylase/C17,20-lyase cytochrome. J Biol Chem 1984; 259: 3971–6.
12. Kominami S, Ochi H, Kobayashi Y, Takemori S. Studies on the steroid hydroxylation system in adrenal cortex microsomes: purification and characterization of cytochrome P-450 specific for steroid C-21 hydroxylation. J Biol Chem 1980; 255: 3386–94.
13. Suhara K, Gomi T, Sato H, Itagaki E, Takemori S, Katagiri M. Purification and immunochemical characterization of the two adrenal cortex mitochondrial cytochrome P-450-proteins. Arch Biochem Biophys 1978; 190: 290–9.
14. John ME. John MC, Simpson ER. Waterman MR. Regulation of cytochrome P-45011β gene expression by adrenocorticotropin. J Biol Chem 1985; 260: 5760–7.
15. John ME, Okamura T. Dee A, et al. Bovine steroid 21-hydroxylase: regulation of biosynthesis. Biochemistry 1986; 25: 2846–53.
16. Zuber MX, John ME, Okamura T. Simpson ER, Waterman MR. Bovine adrenocortical cytochrome P-450l7α. J Biol Chem 1986; 261: 2475–82.
17. Aguilera G, Catt KJ. Regulation of aldosterone secretion by the renin-angiotensin system during sodium restriction in rats. Proc Natl Acad Sci USA 1978; 75: 4057–61.
18. Kuhnle U, Chow D, Rapaport R, Pang S, Levine LS, New MI. The 21-hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia. J Clin Endocrinol Metab 1981; 52: 534–44.
19. Yanagibashi K, Haniu M, Shively JE, Shen WH. Hall P. The synthesis of aldosterone by the adrenal cortex: two zones (fasciculata and glomerulosa) possess one enzyme for 11β-, 18-hydroxylation, and aldehyde synthesis. J Biol Chem 1986; 261: 3556–62.
20. Müller W, Prader A, Kofler J, Glatzl J, Geir W. Zur Häufigkeit des kongenitalen adrenogenitalen Syndroms (AGS). Paediatr Paedol 1979; 14: 151–5.
21. Pang S. Murphey W, Levine LS, et al. A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 1982; 55: 413–20.
22. Cacciari E. Balsamo A, Cassio A, et al. Neonatal screening for congenital adrenal hyperplasia. Arch Dis Child 1983; 58: 803–6.
23. Grumbach MM, Conte FA. Disorders of sexual differentiation. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology. 7th ed. Philadelphia: W.B. Saunders, 1985:312–401.
24. Mulaikal RM. Migeon CJ. Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316: 178–82.
25. Richards GE, Grumbach MM. Kaplan SL, et al. The effect of long acting glucocorticoids in menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. J Clin Endocrinol Metab 1978; 47: 1208–15.
26. Urban MD, Lee PA, Migeon CJ. Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N Engl J Med 1978; 299: 1392–6.
27. Wischusen J, Baker HWG, Hudson B. Reversible male infertility due to congenital adrenal hyperplasia. Clin Endocrinol 1981; 14: 571–7.
28. Laron Z, Pollack MS, Zamir R, et al. Late onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: a new allele at the 21-hydroxylase locus. Hum Immunol 1980; 1: 55–66.
29. Kohn B, Levine LS. Pollack MS, et al. Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 1982; 55: 817–27.
30. Levine LS, Dupont B. Lorenzen F, et al. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab 1981; 53: 1193–8.
31. Speiser PW, Dupont B. Rubinstein P. Piazza A. Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37: 650–67.
32. Birnbaum MD, Rose LI. Late onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction. Obstet Gynecol 1984; 63: 445–51.
33. New MI. Lorenzen F, Lerner AJ, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983; 57: 320–6.
34. Stoner E, Dimartino-Nardi J, Kuhnle U. Levine LS, Oberfield SE, New MI. Is salt-wasting in congenital adrenal hyperplasia due to the same gene as the fasciculata defect? Clin Endocrinol 1986; 24: 9–20.
35. Winter JSD. Current approaches to the treatment of congenital adrenal hyperplasia. J Pediatr 1980; 97: 81–2.
36. Rösler A, Levine LS, Schneider B, Novogroder M, New MI. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J Clin Endocrinol Metab 1977; 45: 500–12.
37. Homer JM, Hintz RL, Leutscher JA. The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia. J Clin Endocrinol Metab 1979; 48: 776–83.
38. Mininberg DT, Levine LS, New MI. Current concepts in congenital adrenal hyperplasia. Invest Urol 1979; 17: 169–75.
39. Hendren WH, Donohoe PK. Correction of congenital abnormalities of the vagina and perineum. J Pediatr Surg 1980; 15: 751–63.
40. Federman DD. Psychosexual adjustment in congenital adrenal hyperplasia. N Engl J Med 1987; 316: 209–11.
41. Dupont B, Oberfield SE, Smithwick EM, Lee TD, Levine LS. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet 1977; 2: 1309–11.
42. Levine LS, Zachmann M, New MI, et al. Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group. N Engl J Med 1978; 299: 911–5.
43. Bodmer WF. The HLA system, 1984. In: Albert ED. Baur MP, Mayr WR, eds. Histocompatibility testing 1984: report on the Ninth International Histocompatibility Workshop and Conference. Berlin: Springer-Verlag, 1984:11–22.
44. Dupont B, Pollack MS, Levine LS, O'Neill GJ, Hawkins BR, New MI. Congenital adrenal hyperplasia. In: Terasaki PI, ed. Histocompatibility testing 1980. Los Angeles: UCLA Tissue Typing Laboratory, 1980:693–706.
45. Awdeh ZL, Raum D. Yunis EJ, Alper CA. Extended HLA/complement allele haplotypes: evidence forT/t-like complex in man. Proc Natl Acad Sci USA 1983; 80: 259–63.
46. Klouda PT, Harris R. Price DA. Linkage and association between HLA and 21-hydroxylase deficiency. J Med Genet 1980; 17: 337–41.
47. Dupont B, Virdis R, Lerner AJ, Nelson C. Pollack MS, New MI. Distinct HLA-B antigen associations for the salt-wasting and simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. In: Albert ED. Baur MP, Mayr WR, eds. Histocompatibility testing 1984. Berlin: Springer-Verlag. 1984:660.
48. Fleischnick E, Awdeh ZL, Raum D, et al. Extended MHC haplotypes in 21-hydroxylase deficiency congenital adrenal hyperplasia: shared genotypes in unrelated patients. Lancet 1983; 1: 152–6.
49. O'Neill GJ, Dupont B, Pollack MS, Levine LS, New MI. Complement C4 allotypes in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: further evidence for different allelic variants at the 21-hydroxylase locus. Clin Immunol Immunopathol 1982: 23: 312–22.
50. Raum D. Awdeh Z. Anderson J, et al. Human C4 haplotypes with duplicated C4A or C4B. Am J Hum Genet 1984; 36: 72–9.
51. Speiser PW, New MI. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 1987; 64: 86–91.